Search - tctmd.com

Displaying 441 - 460 of 586

Sort: Relevancy | Date

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

L.A. McKeown

December 05, 2012

Presentation

Randomized Assessment of Ticagrelor vs. Prasugrel: Antiplatelet Effects in Patients with STEMI

Presenter: Dimitrios Alexopoulos

December 03, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

Platelet Reactivity in Response to Prasugrel Depends on the Test

November 04, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Conference News AHA 2012

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Jason Kahn

November 04, 2012

Presentation TCT 2012

Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases!

Presenter: Dominick Angiolillo

October 25, 2012

News Conference News TCT 2012

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

Presentation TCT 2012

Prasugrel Update: TRILOGY

Presenter: E. Magnus Ohman

October 24, 2012

Presentation TCT 2012

Prasugrel Is the Gold Standard!

Presenter: Matthew Price

October 24, 2012

News Conference News TCT 2012

Wednesday, TCT 2012 Dailies

October 24, 2012

Presentation TCT 2012

TRILOGY ACS Angiographic Cohort: A Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in Patients with Non-ST-Segment Elevation ACS Who Are Medically Managed After...

Presenter: Stephen Wiviott

October 24, 2012

News Conference News TCT 2012

Tailored Clopidogrel Therapy Bests Prasugrel at Control of Platelet Reactivity in ACS

October 24, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Conference News TCT 2012

Presentations Examine Multiple Facets of Antiplatelet Agents

October 24, 2012

Presentation TCT 2012

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

Presenter: Paul Gurbel

October 23, 2012

Presentation TCT 2012

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

Presenter: Renato Valenti

October 23, 2012

Advertisement

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

Randomized Assessment of Ticagrelor vs. Prasugrel: Antiplatelet Effects in Patients with STEMI

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Platelet Reactivity in Response to Prasugrel Depends on the Test

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases!

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Prasugrel Update: TRILOGY

Prasugrel Is the Gold Standard!

Wednesday, TCT 2012 Dailies

TRILOGY ACS Angiographic Cohort: A Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in Patients with Non-ST-Segment Elevation ACS Who Are Medically Managed After...

Tailored Clopidogrel Therapy Bests Prasugrel at Control of Platelet Reactivity in ACS

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Presentations Examine Multiple Facets of Antiplatelet Agents

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content